Global Medical REIT, Inc. operates as a development stage company that intends to develop and manage a portfolio of healthcare real estate assets and properties. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Real estate investment trusts
Sub-IndustryN/A
SectorFinance
Current SymbolNYSE:GMRE
Previous Symbol
CUSIPN/A
Phone202-524-6851
Debt
Debt-to-Equity Ratio1.66
Current Ratio0.09
Quick Ratio0.09
Price-To-Earnings
Trailing P/E Ratio17.56
Forward P/E Ratio11.85
P/E Growth1.31
Sales & Book Value
Annual Sales$30.34 million
Price / Sales6.88
Cash Flow$0.5290 per share
Price / Cash17.92
Book Value$8.16 per share
Price / Book1.16
Profitability
EPS (Most Recent Fiscal Year)$0.54
Net Income$-30,000.00
Net Margins9.87%
Return on Equity2.65%
Return on Assets0.87%
Miscellaneous
Employees9
Outstanding Shares22,030,000
Market Cap$206.39 million
OptionableOptionable
Global Medical REIT (NYSE:GMRE) Frequently Asked Questions
What is Global Medical REIT's stock symbol?
Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."
How often does Global Medical REIT pay dividends? What is the dividend yield for Global Medical REIT?
Global Medical REIT announced a quarterly dividend on Tuesday, September 11th. Stockholders of record on Thursday, September 20th will be given a dividend of $0.20 per share on Wednesday, October 10th. This represents a $0.80 annualized dividend and a dividend yield of 8.51%. The ex-dividend date is Wednesday, September 19th. View Global Medical REIT's Dividend History.
How were Global Medical REIT's earnings last quarter?
Global Medical REIT Inc (NYSE:GMRE) released its earnings results on Monday, November, 5th. The company reported $0.01 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.23 by $0.22. The firm earned $14 million during the quarter, compared to the consensus estimate of $14.34 million. Global Medical REIT had a net margin of 9.87% and a return on equity of 2.65%. View Global Medical REIT's Earnings History.
When is Global Medical REIT's next earnings date?
What price target have analysts set for GMRE?
5 brokers have issued 12 month price objectives for Global Medical REIT's stock. Their predictions range from $8.00 to $12.00. On average, they expect Global Medical REIT's stock price to reach $10.60 in the next twelve months. This suggests a possible upside of 12.8% from the stock's current price. View Analyst Price Targets for Global Medical REIT.
What is the consensus analysts' recommendation for Global Medical REIT?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Global Medical REIT.
What are Wall Street analysts saying about Global Medical REIT stock?
Here are some recent quotes from research analysts about Global Medical REIT stock:
- 1. According to Zacks Investment Research, "Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to clinical operators. Global Medical REIT Inc. is based in Denver, United States. " (11/9/2018)
- 2. Cantor Fitzgerald analysts commented, "GMRE reported in-line 4Q17 results in a relatively clean but active quarter in terms of M&A and balance sheet developments." (3/7/2018)
Has Global Medical REIT been receiving favorable news coverage?
News headlines about GMRE stock have trended somewhat negative this week, InfoTrie reports. The research firm ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Global Medical REIT earned a news impact score of -1.9 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future.
Who are some of Global Medical REIT's key competitors?
Some companies that are related to Global Medical REIT include Northstar Realty Europe (NRE), Granite Point Mortgage Trust (GPMT), Urstadt Biddle Properties (UBA), CIM Commercial Trust (CMCT), NexPoint Residential Trust (NXRT), istar (STAR), Hersha Hospitality Trust (HT), Urstadt Biddle Properties (UBP), CAPSTEAD Mtg Co/SH (CMO), Investors Real Estate Trust Reit (IRET), Preferred Apartment Communities (APTS), Pennsylvania R.E.I.T. (PEI), Essential Properties Realty Trust (EPRT), Whitestone REIT (WSR) and Community Healthcare Trust (CHCT).
Who are Global Medical REIT's key executives?
Global Medical REIT's management team includes the folowing people:
- Jeffrey Mark Busch, Chairman, President & Chief Executive Officer
- Danica Holley, Chief Operating Officer
- Robert J. Kiernan, Chief Financial Officer & Treasurer
- Alfonzo Leon, Chief Investment Officer
- Allen E. Webb, Senior VP-SEC Reporting & Technical Accounting
When did Global Medical REIT IPO?
(GMRE) raised $130 million in an IPO on Wednesday, June 29th 2016. The company issued 13,000,000 shares at a price of $10.00 per share. Wunderlich and Oppenheimer served as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.
Who are Global Medical REIT's major shareholders?
Global Medical REIT's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (4.72%), State of New Jersey Common Pension Fund D (2.02%), Bank of New York Mellon Corp (0.88%), Renaissance Technologies LLC (0.66%), Wedge Capital Management L L P NC (0.57%) and D.A. Davidson & CO. (0.54%). Company insiders that own Global Medical REIT stock include Henry Cole, Jeffrey Busch, Matthew Cypher and Ronald Marston. View Institutional Ownership Trends for Global Medical REIT.
Which institutional investors are selling Global Medical REIT stock?
GMRE stock was sold by a variety of institutional investors in the last quarter, including GSA Capital Partners LLP, Renaissance Technologies LLC, JPMorgan Chase & Co., JPMorgan Chase & Co., D.A. Davidson & CO., Janney Montgomery Scott LLC, Rational Advisors LLC and Citadel Advisors LLC. View Insider Buying and Selling for Global Medical REIT.
Which institutional investors are buying Global Medical REIT stock?
GMRE stock was bought by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Chicago Equity Partners LLC, Martingale Asset Management L P, State of New Jersey Common Pension Fund D, BlackRock Inc., Dimensional Fund Advisors LP and Bank of New York Mellon Corp. Company insiders that have bought Global Medical REIT stock in the last two years include Henry Cole, Jeffrey Busch, Matthew Cypher and Ronald Marston. View Insider Buying and Selling for Global Medical REIT.
How do I buy shares of Global Medical REIT?
Shares of GMRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Global Medical REIT's stock price today?
One share of GMRE stock can currently be purchased for approximately $9.40.
How big of a company is Global Medical REIT?
Global Medical REIT has a market capitalization of $206.39 million and generates $30.34 million in revenue each year. The company earns $-30,000.00 in net income (profit) each year or $0.54 on an earnings per share basis. Global Medical REIT employs 9 workers across the globe.
What is Global Medical REIT's official website?
How can I contact Global Medical REIT?
Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The company can be reached via phone at 202-524-6851.
MarketBeat Community Rating for Global Medical REIT (NYSE GMRE)
MarketBeat's community ratings are surveys of what our community members think about Global Medical REIT and other stocks. Vote "Outperform" if you believe GMRE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GMRE will underperform the S&P 500 over the long term. You may vote once every thirty days.
